Otrivin Nasal Spray

Otrivin is a globally recognized brand specializing in nasal decongestants and sinus care. It was originally developed in Switzerland by the pharmaceutical company Ciba-Geigy. The brand became a staple in the Novartis portfolio for many years following the merger of Ciba-Geigy and Sandoz.

In recent years, the ownership of Otrivin moved to Haleon (formerly GSK Consumer Healthcare), which became an independent company in 2022. Haleon is headquartered in the United Kingdom and manages many of the world's most popular consumer health brands. Manufacturing of Otrivin occurs across several specialized pharmaceutical facilities worldwide, including locations in Switzerland, India, and Germany, to meet global demand for cold and allergy relief.